Q-Nasl is a "dry" version of the steroidal sprays many allergy sufferers already use.
But it's less likely to cause the post-nasal drip that "wet" sprays do.
One of the doctors who tested Q-Nasl believes it could get more allergy sufferers to get treatment.
"Many patients that I see refuse to even try one of the most effective medical treatments, saying they do not like to spray things in their nose," says Dr. Gary Gross, of the Dallas Asthma and Allergy Center.
"Or they don't like the feeling of the spray dripping down the back of the throat," he add.
"When I show them an alternative of a dry nasal spray, they accept it and often come back thanking me for making their lives so much better," says Dr. Gross.
The side effects of Q-Nasl are similar to the wet sprays: nosebleeds or headaches.
Teva Pharmaceuticals, the maker of Q-Nasl, says it will be available by prescription by late April.
